April 17 (Reuters) - Eurofins Scientific SE:
* EUROFINS TECHNOLOGIES LAUNCHES MULTIPLE CE-IVD MARKED SEROLOGIC PRODUCTS FOR THE DETECTION OF ANTIBODIES IN PATIENTS WHO HAVE BEEN EXPOSED TO SARS-COV-2 (COVID-19)
* ANNOUNCES CE-IVD MARKING OF A FIRST RANGE OF TESTING KITS FOR SEROLOGY-BASED ANTIBODY DETECTION BY ELISA OF PATIENTS WHO HAVE BEEN EXPOSED TO COVID-19
* EUROFINS TECHNOLOGIES SCIENTIFIC EXPERTS WILL CONTINUE TO WORK ON DEVELOPMENT OF ADDITIONAL SEROLOGICAL TESTS
* EUROFINS TECHNOLOGIES SCIENTIFIC EXPERTS WILL CONTINUE TO WORK ON DEVELOPMENT OF ADDITIONAL SEROLOGICAL TESTS
* EUROFINS TECHNOLOGIES COMPANIES WILL IMMEDIATELY START SHIPMENTS IN SIGNIFICANT QUANTITIES
* OUR FOUR FACTORIES AND PARTNERS ARE RAMPING UP TO PRODUCE KITS TO CARRY OUT OVER 10 MILLION TESTS PER MONTH Further company coverage: (Reporting by Sudip Kar-Gupta)
Our Standards: The Thomson Reuters Trust Principles.